230 related articles for article (PubMed ID: 22505514)
1. Kallikrein-related peptidases in prostate, breast, and ovarian cancers: from pathobiology to clinical relevance.
Avgeris M; Mavridis K; Scorilas A
Biol Chem; 2012 Apr; 393(5):301-17. PubMed ID: 22505514
[TBL] [Abstract][Full Text] [Related]
2. Kallikrein-related peptidases in cancers of gastrointestinal tract: an inside view of their role and clinical significance.
Linardoutsos D; Gazouli M; Machairas A; Bramis I; Zografos GC
J BUON; 2014; 19(1):53-9. PubMed ID: 24659643
[TBL] [Abstract][Full Text] [Related]
3. Kallikrein-related peptidases (KLKs) as emerging therapeutic targets: focus on prostate cancer and skin pathologies.
Avgeris M; Scorilas A
Expert Opin Ther Targets; 2016 Jul; 20(7):801-18. PubMed ID: 26941073
[TBL] [Abstract][Full Text] [Related]
4. Kallikrein-related peptidase genes as promising biomarkers for prognosis and monitoring of human malignancies.
Avgeris M; Mavridis K; Scorilas A
Biol Chem; 2010 May; 391(5):505-11. PubMed ID: 20302518
[TBL] [Abstract][Full Text] [Related]
5. Predictions for the future of kallikrein-related peptidases in molecular diagnostics.
Scorilas A; Mavridis K
Expert Rev Mol Diagn; 2014 Jul; 14(6):713-22. PubMed ID: 24927162
[TBL] [Abstract][Full Text] [Related]
6. Proteomic and other analyses to determine the functional consequences of deregulated kallikrein-related peptidase (KLK) expression in prostate and ovarian cancer.
Fuhrman-Luck RA; Silva ML; Dong Y; Irving-Rodgers H; Stoll T; Hastie ML; Loessner D; Gorman JJ; Clements JA
Proteomics Clin Appl; 2014 Jun; 8(5-6):403-15. PubMed ID: 24535680
[TBL] [Abstract][Full Text] [Related]
7. Kallikrein-related peptidases (KLKs): a gene family of novel cancer biomarkers.
Kontos CK; Scorilas A
Clin Chem Lab Med; 2012 Nov; 50(11):1877-91. PubMed ID: 23093268
[TBL] [Abstract][Full Text] [Related]
8. Clinical utility of kallikrein-related peptidases (KLK) in urogenital malignancies.
Dorn J; Bayani J; Yousef GM; Yang F; Magdolen V; Kiechle M; Diamandis EP; Schmitt M
Thromb Haemost; 2013 Sep; 110(3):408-22. PubMed ID: 23765253
[TBL] [Abstract][Full Text] [Related]
9. Overview of tissue kallikrein and kallikrein-related peptidases in breast cancer.
Figueroa CD; Molina L; Bhoola KD; Ehrenfeld P
Biol Chem; 2018 Sep; 399(9):937-957. PubMed ID: 29885274
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of kallikrein-related peptidases: there is a whole new world out there.
Pasic MD; Olkhov E; Bapat B; Yousef GM
Biol Chem; 2012 Apr; 393(5):319-30. PubMed ID: 22505515
[TBL] [Abstract][Full Text] [Related]
11. Kallikrein-related peptidases (KLKs) in gastrointestinal cancer: mechanistic and clinical aspects.
Kontos CK; Mavridis K; Talieri M; Scorilas A
Thromb Haemost; 2013 Sep; 110(3):450-7. PubMed ID: 23446315
[TBL] [Abstract][Full Text] [Related]
12. Human tissue kallikreins: the cancer biomarker family.
Paliouras M; Borgono C; Diamandis EP
Cancer Lett; 2007 Apr; 249(1):61-79. PubMed ID: 17275179
[TBL] [Abstract][Full Text] [Related]
13. Human kallikrein-related peptidase 12: antibody generation and immunohistochemical localization in prostatic tissues.
Memari N; Diamandis EP; Earle T; Campbell A; Van Dekken H; Van der Kwast TH
Prostate; 2007 Sep; 67(13):1465-74. PubMed ID: 17654496
[TBL] [Abstract][Full Text] [Related]
14. Targeting kallikrein-related peptidases in prostate cancer.
Mavridis K; Avgeris M; Scorilas A
Expert Opin Ther Targets; 2014 Apr; 18(4):365-83. PubMed ID: 24571737
[TBL] [Abstract][Full Text] [Related]
15. Human kallikrein 14: a new potential biomarker for ovarian and breast cancer.
Borgoño CA; Grass L; Soosaipillai A; Yousef GM; Petraki CD; Howarth DH; Fracchioli S; Katsaros D; Diamandis EP
Cancer Res; 2003 Dec; 63(24):9032-41. PubMed ID: 14695222
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value and biological role of the kallikrein-related peptidases in human malignancies.
Mavridis K; Scorilas A
Future Oncol; 2010 Feb; 6(2):269-85. PubMed ID: 20146586
[TBL] [Abstract][Full Text] [Related]
17. Seminal fluid characterization for male fertility and prostate cancer: kallikrein-related serine proteases and whole proteome approaches.
Veveris-Lowe TL; Kruger SJ; Walsh T; Gardiner RA; Clements JA
Semin Thromb Hemost; 2007 Feb; 33(1):87-99. PubMed ID: 17253195
[TBL] [Abstract][Full Text] [Related]
18. Kallikrein-related peptidases targeted therapies in prostate cancer: perspectives and challenges.
Cereda V; Formica V; Menghi A; Pellicori S; Roselli M
Expert Opin Investig Drugs; 2015; 24(7):929-47. PubMed ID: 25858813
[TBL] [Abstract][Full Text] [Related]
19. Interdependence of kallikrein-related peptidases in proteolytic networks.
Beaufort N; Plaza K; Utzschneider D; Schwarz A; Burkhart JM; Creutzburg S; Debela M; Schmitt M; Ries C; Magdolen V
Biol Chem; 2010 May; 391(5):581-7. PubMed ID: 20302517
[TBL] [Abstract][Full Text] [Related]
20. Tissue kallikrein proteolytic cascade pathways in normal physiology and cancer.
Pampalakis G; Sotiropoulou G
Biochim Biophys Acta; 2007 Sep; 1776(1):22-31. PubMed ID: 17629406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
